Global Nuclear Medicine Imaging Equipment Market Size By Type (Full Ring PET Scanners, Partial Ring PET Scanners), By Application (Oncology, Cardiology), By Region, And Segment Forecasts, 2023 to 2032

The Global Nuclear Medicine Imaging Equipment Market was valued at USD 3.9 billion in 2023 and is projected to reach USD 7.2 billion by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. The increasing incidence of cancer and cardiovascular diseases, coupled with the rising geriatric population, is significantly driving demand for nuclear medicine imaging systems. These systems are critical in early diagnosis, therapy monitoring, and disease staging, offering precise and functional imaging beyond anatomical data. Technological advancements such as hybrid imaging systems (SPECT/CT, PET/CT), growing preference for minimally invasive diagnostics, and government initiatives to promote cancer screening are further contributing to market expansion.

Drivers:

1. Rising Prevalence of Chronic Diseases:

The increasing global burden of cancer, cardiac ailments, and neurological disorders is propelling the demand for advanced imaging modalities like SPECT and PET. Early and accurate diagnosis using nuclear medicine imaging is vital in clinical decision-making and disease management.

2. Advancements in Radiotracers and Imaging Technology:

The development of novel radiopharmaceuticals and the integration of AI in imaging systems have greatly enhanced image clarity, diagnostic precision, and workflow efficiency. These innovations are making nuclear imaging more accessible and accurate.

3. Government and Private Sector Investments in Healthcare Infrastructure:

Increased investments in medical imaging infrastructure, particularly in developing nations, along with supportive reimbursement policies in countries like the U.S., are facilitating wider adoption of nuclear imaging systems.

Restraints:

1. High Cost of Equipment and Radiopharmaceuticals:

Nuclear imaging systems, particularly PET/CT and PET/MRI, involve high capital investment. Additionally, the cost of producing and transporting radiopharmaceuticals can be prohibitive, limiting their availability in low-resource settings.

2. Regulatory Hurdles and Short Half-Life of Isotopes:

Stringent regulatory requirements for radiotracer approval and the logistical challenges of isotopes with short half-lives are hampering the widespread application of nuclear imaging, especially in remote areas.

Opportunity:

1. Growth in Hybrid Imaging and AI Integration:

The increasing preference for hybrid imaging modalities such as SPECT/CT and PET/CT, which combine anatomical and functional imaging, presents substantial growth opportunities. Integration with AI is expected to further enhance diagnostic capabilities and workflow automation.

2. Expansion in Emerging Markets:

Countries in Asia-Pacific and Latin America are experiencing rapid healthcare modernization. The rising healthcare expenditure, increasing awareness of early disease detection, and growing number of diagnostic centers create lucrative opportunities for market players.

Market by System Type Insights:

The SPECT (Single Photon Emission Computed Tomography) segment accounted for the largest share of the market in 2023, driven by its wide application in cardiology and oncology and relatively lower cost compared to PET systems. However, the PET (Positron Emission Tomography) segment is projected to witness the fastest growth due to its superior resolution and increased usage in neurology and cancer diagnosis.

Market by End-use Insights:

Hospitals emerged as the dominant end-user segment in 2023, contributing over 50% of the global revenue share. Their access to advanced imaging infrastructure, skilled radiologists, and high patient volume drives this dominance. Diagnostic Imaging Centers are anticipated to grow significantly due to increasing outsourcing of imaging services and the growing availability of outpatient diagnostic services.

Market by Regional Insights:

North America led the global market in 2023, attributed to the presence of leading medical imaging companies, robust healthcare infrastructure, and high adoption of advanced technologies. Asia-Pacific is expected to be the fastest-growing region during the forecast period, fueled by rising healthcare investments, increasing patient awareness, and expanding diagnostic imaging networks in China, India, and Southeast Asia.

Competitive Scenario:

Prominent players in the Global Nuclear Medicine Imaging Equipment Market include GE HealthCare, Siemens Healthineers, Canon Medical Systems Corporation, Philips Healthcare, Digirad Corporation, Mediso Ltd., MILabs B.V., and Neusoft Medical Systems. These companies are investing in R&D to develop compact, AI-integrated, and multi-modal imaging systems. Strategic collaborations, FDA approvals, and expansion into emerging markets are key tactics to strengthen their market presence.

Scope of Work – Global Nuclear Medicine Imaging Equipment Market

Report Metric Details

Market Size (2023) USD 3.9 billion

Projected Market Size (2031) USD 7.2 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (SPECT, PET, Planar Scintigraphy), By End-use (Hospitals, Diagnostic Imaging Centers, Research Institutes), By Region

Growth Drivers Rising incidence of cancer and cardiovascular diseases, Advancements in radiotracers and hybrid imaging, Government support for early diagnostics

Opportunities AI integration in imaging, Emerging market expansion, Development of cost-effective and compact imaging systems

Key Market Developments:

2023: GE HealthCare launched its next-generation SPECT/CT system featuring deep learning algorithms for improved cardiac and oncology imaging.

2024: Siemens Healthineers received FDA approval for its Biograph Vision Quadra PET/CT, a digital scanner designed for whole-body imaging with ultra-fast acquisition time.

2025: Canon Medical Systems expanded its presence in Southeast Asia with a new PET/MRI training and service center in Singapore to cater to regional demand.

FAQs:

1. What is the current market size of the Global Nuclear Medicine Imaging Equipment Market?

The market was valued at USD 3.9 billion in 2023.

2. What is the major growth driver of the Global Nuclear Medicine Imaging Equipment Market?

The rising prevalence of cancer and cardiovascular diseases and the demand for early, accurate diagnostics are the major growth drivers.

3. Which is the largest region during the forecast period in the Global Nuclear Medicine Imaging Equipment Market?

North America is the largest region due to advanced healthcare infrastructure and high adoption of imaging technologies.

4. Which segment accounted for the largest market share in the Global Nuclear Medicine Imaging Equipment Market?

The SPECT segment held the largest market share in 2023.

5. Who are the key market players in the Global Nuclear Medicine Imaging Equipment Market?

Key players include GE HealthCare, Siemens Healthineers, Canon Medical Systems, Philips Healthcare, Digirad Corporation, and Mediso Ltd.